Secretary of Veterans Affairs Denis McDonough
SPOKANE, Wash. The Secretary of the U.S. Department of Veterans Affairs, Denis McDonough, is visiting the Mann-Grandstaff VA Medical Center in Spokane Wednesday evening.
The VA says McDonough will be there to get feedback from veterans and employees, and observe the impact of national-level decisions on local VA operations.
McDonough was sworn in as Secretary of Veterans Affairs on February 9, 2021.
COPYRIGHT 2021 BY KXLY. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.
Hampton VA union members honor colleagues, veterans lost to COVID-19
and last updated 2021-04-28 22:58:59-04
HAMPTON, Va. - Hundreds of Department of Veterans Affairs union members from the American Federation of Government Employeesâ National VA Council, the union representing over 265,000 VA workers joined together on Wednesday afternoon for the annual Workers Memorial Day.
Workers in cities across the country, including AFGE Local 2828, assembled to honor the lives of VA workers and veterans lost to COVID-19, fight for better workplace protections and demand fair contracts. This is not the first rally and it will not be the last. We re out here for life, said Registered Nurse at the Hampton VA Medical Center, Stephanie Vick.
By Staff
Maine s congressional delegation is pressing the Biden administration not to delay construction of a new veterans mental health and substance use disorder facility at the Togus VA Medical Center near Augusta.
A letter to U.S. Secretary of Veterans Affairs Denis McDonough raises concerns about a possible delay to a planned 24-bed treatment center at Togus under new guidance from the Veterans Administration, and asks that the project be given expedited priority. The timely construction and completion of this facility is crucial for the mental health and well-being of Maine veterans, the delegation says in a three-page letter dated April 22.
April 16, 2021 6:10 AM By Brandon Lee
Lawmakers seeking to lower drug costs should take a comprehensive approach rather than focus solely on manufacturersâ pricing practicesâa strategy thatâs only created disparities in the marketplace, policy analysts say.
Drug pricing will come back to the forefront of policy discussions in the coming months as Covid-19 vaccines become more readily available and lawmakers turn to other issues. But many of the roughly two dozen bills floating around Congress primarily address the prices drug companies set and ignore other aspects of the supply chain, including the pharmacy middlemen that control how insurance pays for medications.